165 related articles for article (PubMed ID: 25170299)
1. Heterogeneity of osteosarcoma cell lines led to variable responses in reprogramming.
Choong PF; Teh HX; Teoh HK; Ong HK; Choo KB; Sugii S; Cheong SK; Kamarul T
Int J Med Sci; 2014; 11(11):1154-60. PubMed ID: 25170299
[TBL] [Abstract][Full Text] [Related]
2. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
[TBL] [Abstract][Full Text] [Related]
3. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
4. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
5. Expression level of pluripotent genes in incomplete reprogramming.
Zhao X; Li Q; Jiang WM; Liu HY; Ma N; Zhou Z; Li LJ; Huang YH; Ma YL
Asian Pac J Trop Med; 2014 Aug; 7(8):639-644. PubMed ID: 25149378
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.
Cevallos RR; Hossain ME; Zhang R; Hu K
Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623
[TBL] [Abstract][Full Text] [Related]
7. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
8. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
[TBL] [Abstract][Full Text] [Related]
9. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Human Oral Squamous Cell Carcinoma (OSCC) H103 and H376 cell lines to Retroviral OSKM mediated reprogramming.
Verusingam ND; Yeap SK; Ky H; Paterson IC; Khoo SP; Cheong SK; Ong AHK; Kamarul T
PeerJ; 2017; 5():e3174. PubMed ID: 28417059
[TBL] [Abstract][Full Text] [Related]
11. Pinacidil enhances survival of cryopreserved human embryonic stem cells.
Barbaric I; Jones M; Buchner K; Baker D; Andrews PW; Moore HD
Cryobiology; 2011 Dec; 63(3):298-305. PubMed ID: 22027383
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming pig fetal fibroblasts reveals a functional LIF signaling pathway.
Thomson AJ; Pierart H; Meek S; Bogerman A; Sutherland L; Murray H; Mountjoy E; Downing A; Talbot R; Sartori C; Whitelaw CB; Freeman TC; Archibald AL; Burdon T
Cell Reprogram; 2012 Apr; 14(2):112-22. PubMed ID: 22339199
[TBL] [Abstract][Full Text] [Related]
13. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V.
Tavakoli T; Xu X; Derby E; Serebryakova Y; Reid Y; Rao MS; Mattson MP; Ma W
BMC Cell Biol; 2009 Jun; 10():44. PubMed ID: 19500347
[TBL] [Abstract][Full Text] [Related]
14. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.
Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I
Oncogene; 2013 May; 32(18):2249-60, 2260.e1-21. PubMed ID: 22777357
[TBL] [Abstract][Full Text] [Related]
15. Demarcation of stable subpopulations within the pluripotent hESC compartment.
Bhatia S; Pilquil C; Roth-Albin I; Draper JS
PLoS One; 2013; 8(2):e57276. PubMed ID: 23437358
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming of the germ cell nuclear factor gene is required for proper differentiation of induced pluripotent cells.
Wang H; Wang X; Xu X; Zwaka TP; Cooney AJ
Stem Cells; 2013 Dec; 31(12):2659-66. PubMed ID: 23495137
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expanded SSEA-4+ human limbal stromal cells are multipotent and do not express other embryonic stem cell markers.
Lim MN; Hussin NH; Othman A; Umapathy T; Baharuddin P; Jamal R; Zakaria Z
Mol Vis; 2012; 18():1289-300. PubMed ID: 22665977
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming.
Redmer T; Diecke S; Grigoryan T; Quiroga-Negreira A; Birchmeier W; Besser D
EMBO Rep; 2011 Jul; 12(7):720-6. PubMed ID: 21617704
[TBL] [Abstract][Full Text] [Related]
19. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
20. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
